| Bioactivity | IMT504, a non-CpG 24-mer oligodeoxynucleotide, is an immunomodulatory oligonucleotide currently being investigated as a rabies vaccine. IMT504 has been previously proven to be effective in animal models of vaccine potency, chronic lymphocytic leukemia, tissue regeneration, and sepsis. |
| CAS | 1075758-80-3 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Franco R, Rodriguez JM, Elías F, et al. Non-clinical safety studies of IMT504, a unique non-CpG oligonucleotide. Nucleic Acid Ther. 2014;24(4):267-282. doi:10.1089/nat.2013.0479 |